Smith & Nephew SNATS Change in Accounts Payable 2010-2024 | SNN
Smith & Nephew SNATS annual/quarterly change in accounts payable history and growth rate from 2010 to 2024. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- Smith & Nephew SNATS change in accounts payable for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS change in accounts payable for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS annual change in accounts payable for 2024 was $0.016B, a 115.24% decline from 2023.
- Smith & Nephew SNATS annual change in accounts payable for 2023 was $-0.105B, a 320% increase from 2022.
- Smith & Nephew SNATS annual change in accounts payable for 2022 was $-0.025B, a 130.49% decline from 2021.
| Smith & Nephew SNATS Annual Change in Accounts Payable (Millions of US $) |
|
|---|---|
| 2024 | $16 |
| 2023 | $-105 |
| 2022 | $-25 |
| 2021 | $82 |
| 2020 | $-103 |
| 2019 | $201 |
| 2018 | $71 |
| 2017 | $-45 |
| 2016 | $-49 |
| 2015 | $216 |
| 2014 | $86 |
| 2013 | $122 |
| 2012 | $N/A |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $12.539B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.146B | 27.67 |
| Boston Scientific (BSX) | United States | $150.504B | 37.68 |
| Stryker (SYK) | United States | $142.511B | 29.80 |
| EssilorLuxottica (ESLOY) | France | $130.598B | 0.00 |
| Medtronic (MDT) | Ireland | $110.517B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.287B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.240B | 26.92 |
| ResMed (RMD) | United States | $36.670B | 27.54 |
| Agilent Technologies (A) | United States | $32.977B | 21.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.574B | 15.47 |
| Terumo (TRUMY) | Japan | $26.206B | 34.04 |
| Insulet (PODD) | United States | $21.421B | 84.09 |
| Koninklijke Philips (PHG) | Netherlands | $20.782B | 14.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.848B | 11.46 |
| Baxter (BAX) | United States | $15.354B | 11.46 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.087B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.271B | 21.82 |
| Lantheus Holdings (LNTH) | United States | $5.391B | 13.60 |
| Prestige Consumer Healthcare (PBH) | United States | $4.135B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.612B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.315B | 15.10 |
| ICU Medical (ICUI) | United States | $3.199B | 23.59 |
| Envista Holdings (NVST) | United States | $3.124B | 25.96 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.614B | 0.00 |
| Acuren (TIC) | United States | $1.361B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.66 |
| Neogen (NEOG) | United States | $1.146B | 14.67 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.57 |
| BioLife Solutions (BLFS) | United States | $1.033B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.845B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.774B | 0.00 |
| CeriBell (CBLL) | United States | $0.641B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Owens & Minor (OMI) | United States | $0.583B | 4.83 |
| Capricor Therapeutics (CAPR) | United States | $0.557B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.532B | 0.00 |
| Valneva SE (VALN) | France | $0.500B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.331B | 58.80 |
| VAREX IMAGING (VREX) | United States | $0.320B | 11.77 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.08 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.233B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 54.95 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.184B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.28 |
| Exagen (XGN) | United States | $0.165B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.72 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.26 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.076B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| United-Guardian (UG) | United States | $0.038B | 12.97 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |